Fox Run Management’s Teva Pharmaceuticals TEVA Stock Holding History

Fox Run Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-43,333	Closed	-$611K	–	1074
2024 Q1	$611K	Sell	43,333 -3,263	-7%	-$41.1K	0.13%	295
2023 Q4	$486K	Buy	+46,596	New	+$435K	0.12%	307
2023 Q2	–	Sell	-41,299	Closed	-$365K	–	954
2023 Q1	$365K	Buy	+41,299	New	+$408K	0.12%	341
2022 Q3	–	Sell	-23,001	Closed	-$173K	–	820
2022 Q2	$173K	Buy	+23,001	New	+$200K	0.09%	428
2020 Q4	–	Sell	-10,646	Closed	-$96K	–	288
2020 Q3	$96K	Buy	+10,646	New	+$113K	0.24%	146
2020 Q1	–	Sell	-30,174	Closed	-$296K	–	351
2019 Q4	$296K	Buy	+30,174	New	+$269K	0.24%	204
2019 Q2	–	Sell	-16,205	Closed	-$254K	–	619
2019 Q1	$254K	Buy	16,205 +1,418	+10%	+$25K	0.14%	320
2018 Q4	$228K	Buy	+14,787	New	+$303K	0.12%	367
2018 Q3	–	Sell	-33,600	Closed	-$817K	–	816
2018 Q2	$817K	Buy	33,600 +22,784	+211%	+$465K	0.26%	80
2018 Q1	$185K	Buy	+10,816	New	+$211K	0.04%	643
2017 Q2	–	Sell	-27,500	Closed	-$882K	–	830
2017 Q1	$882K	Buy	+27,500	New	+$938K	0.36%	40
2016 Q3	–	Sell	-4,400	Closed	-$221K	–	689
2016 Q2	$221K	Buy	+4,400	New	+$234K	0.11%	399

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return